References
- Buxbaum J. The amyloidosis. In: Klippel JH, Dieppe PA (eds). Rheumatology Barcelona: Mosby, 1998;27:1–10.
- Srivastava A, Baxi M, Yadav S, et al. Juvenile rheumatoid arthritis with amyloid goiter: report of a case with review of the literature. Endcr Pathol 2001;12:437–41.
- Trainin EB, Spitzer A, Greifer I. Amyloidosis in juvenile rheumatoid arthritis. NY State J Med 1979;78:72–7.
- Habbick BF, McDickon IW. Amyloid goiter in a patient with rheumatoid arthritis. Scot Med J 1967;12:405–7.
- D'Antonio A, Franco R, Sparano L, et al. Amyloid goiter: the first evidence is secondary amyloidosis. Report of five cases and review of literature. Adv Clin Pathol 2000;4:99–106.
- Berglund K, Keller C, Thysell H. Alkylating cytotoxic treatment in renal amyloidosis secondary to rheumatic disease. Ann Rheum Dis 1987;46:757–62.
- Husby G. Treatment of amyloidosis and the rheumatologist: state of the art and perspectives for the future. Scand J Rheumatol 1998;27:161–5.
- Hamed G, Heffess CS, Shmookler BM, Wenig BM. Amyloid goiter: a clinicopathologic study of 14 cases and review of the literature. Am J Clin Pathol 1995;104:306–12.
- Leblanc R, Haddad G, Robitaille Y. Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis. Neuro-surgery 1992;31:586–90.
- Yood RA, Skinner M, Rubinow A, et al. Bleeding manifestations in 100 patients with amyloidosis. J Am Med Assoc 1983;249:1322–4.